Literature DB >> 27943080

Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).

Christoph Klein1.   

Abstract

Severe congenital neutropenia (SCN), originally described by the Swedish pediatrician Rolf Kostmann, constitutes a heterogeneous disorder associated with a dramatic decrease of peripheral neutrophil granulocytes. Patients suffer from life-threatening bacterial infections unless treated by recombinant human granulocyte colony stimulating factor (G-CSF) or allogeneic hematopoietic stem cells. This review is focused on the SCN variant caused by mutations in HCLS1 Associated Protein X-1 (HAX1) (SCN3, "Kostmann Disease"). HAX1 is a ubiquitously expressed protein with pleotropic functions, including control of cellular viability, migration, and cancer progression. Even though scientific evidence on the molecular mechanisms regarding HAX1 accumulates, no unified picture has emerged. This review highlights historical milestones and our current understanding of SCN related to mutations in HAX1.

Entities:  

Keywords:  HAX1; Kostmann’s disease; Severe congenital neutropenia (SCN)

Mesh:

Substances:

Year:  2016        PMID: 27943080     DOI: 10.1007/s10875-016-0358-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  44 in total

1.  The 3' untranslated region of human vimentin mRNA interacts with protein complexes containing eEF-1gamma and HAX-1.

Authors:  May Al-Maghrebi; Hervé Brulé; Marina Padkina; Carrie Allen; W Michael Holmes; Zendra E Zehner
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Molecular interaction between HAX-1 and XIAP inhibits apoptosis.

Authors:  Young Ji Kang; Mi Jang; Yun Kyung Park; Sunghyun Kang; Kwang-Hee Bae; Sayeon Cho; Chong-Kil Lee; Byoung Chul Park; Seung-Wook Chi; Sung Goo Park
Journal:  Biochem Biophys Res Commun       Date:  2010-02-18       Impact factor: 3.575

3.  Transformation of severe congenital neutropenia to early acute lymphoblastic leukemia in a patient with HAX1 mutation and without G-CSF administration or receptor mutation.

Authors:  S Yetgin; L Olcay; A Koç; M Germeshausen
Journal:  Leukemia       Date:  2008-03-20       Impact factor: 11.528

4.  Deregulation of mitochondrial membrane potential by mitochondrial insertion of granzyme B and direct Hax-1 cleavage.

Authors:  Jie Han; Leslie A Goldstein; Wen Hou; Christopher J Froelich; Simon C Watkins; Hannah Rabinowich
Journal:  J Biol Chem       Date:  2010-04-13       Impact factor: 5.157

5.  Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function.

Authors:  Elizabeth Vafiadaki; Despina Sanoudou; Demetrios A Arvanitis; Dawn H Catino; Evangelia G Kranias; Aikaterini Kontrogianni-Konstantopoulos
Journal:  J Mol Biol       Date:  2006-10-21       Impact factor: 5.469

6.  Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons.

Authors:  Jyh-Rong Chao; Evan Parganas; Kelli Boyd; Cheol Yi Hong; Joseph T Opferman; James N Ihle
Journal:  Nature       Date:  2008-02-20       Impact factor: 49.962

7.  The anti-apoptotic protein HAX-1 is a regulator of cardiac function.

Authors:  Wen Zhao; Jason R Waggoner; Zhi-Guo Zhang; Chi Keung Lam; Peidong Han; Jiang Qian; Paul M Schroder; Bryan Mitton; Aikaterini Kontrogianni-Konstantopoulos; Seth L Robia; Evangelia G Kranias
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

8.  Competition through dimerization between antiapoptotic and proapoptotic HS-1-associated protein X-1 (Hax-1).

Authors:  Jason Koontz; Aikaterini Kontrogianni-Konstantopoulos
Journal:  J Biol Chem       Date:  2013-12-17       Impact factor: 5.157

9.  Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency.

Authors:  K Matsubara; K Imai; S Okada; M Miki; N Ishikawa; M Tsumura; T Kato; O Ohara; S Nonoyama; M Kobayashi
Journal:  Haematologica       Date:  2007-12       Impact factor: 9.941

10.  Hax1 regulates neutrophil adhesion and motility through RhoA.

Authors:  Peter J Cavnar; Erwin Berthier; David J Beebe; Anna Huttenlocher
Journal:  J Cell Biol       Date:  2011-04-25       Impact factor: 10.539

View more
  5 in total

1.  Editorial, Journal of Clinical Immunology.

Authors:  Jean-Laurent Casanova; Vincent Bonagura
Journal:  J Clin Immunol       Date:  2019-11       Impact factor: 8.317

Review 2.  The Evidence for Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Neutrophil Disorders: A Comprehensive Review by the Inborn Errors Working Party Group of the EBMT.

Authors:  Shahrzad Bakhtiar; Bella Shadur; Polina Stepensky
Journal:  Front Pediatr       Date:  2019-10-24       Impact factor: 3.418

3.  A zebrafish model for HAX1-associated congenital neutropenia.

Authors:  Larissa Doll; Narges Aghaallaei; Advaita M Dick; Karl Welte; Julia Skokowa; Baubak Bajoghli
Journal:  Haematologica       Date:  2021-05-01       Impact factor: 9.941

4.  HAX1-dependent control of mitochondrial proteostasis governs neutrophil granulocyte differentiation.

Authors:  Yanxin Fan; Marta Murgia; Monika I Linder; Yoko Mizoguchi; Cong Wang; Marcin Łyszkiewicz; Natalia Ziȩtara; Yanshan Liu; Stephanie Frenz; Gabriela Sciuccati; Armando Partida-Gaytan; Zahra Alizadeh; Nima Rezaei; Peter Rehling; Sven Dennerlein; Matthias Mann; Christoph Klein
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

Review 5.  Inborn errors of immunity and related microbiome.

Authors:  Raja Hazime; Fatima-Ezzohra Eddehbi; Saad El Mojadili; Nadia Lakhouaja; Ikram Souli; Abdelmouïne Salami; Bouchra M'Raouni; Imane Brahim; Mohamed Oujidi; Morad Guennouni; Ahmed Aziz Bousfiha; Brahim Admou
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.